GlassScriptPhysician profile
Michael Artigues
NPI 1750363156
$1,951.69
in general payments reported to CMS, 2019-2025
17 companies · $315 in 2025
The $315 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $164 · 2021: $441 · 2022: $96.28 · 2023: $153 · 2024: $493 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $443.47 | 2019-2024 | |
| Glaxosmithkline, LLC. | $433.88 | 2019-2024 | Pediarix, Bexsero, Menveo |
| Supernus Pharmaceuticals, INC. | $252.17 | 2021-2025 | Qelbree, Qelbree |
| Regeneron Healthcare Solutions, INC. | $154.19 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $134.84 | 2022-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $124.99 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.82 | 2020-2021 | |
| Pfizer INC. | $89.57 | 2025 | |
| Corium, LLC | $57.79 | 2022-2023 | Azstarys |
| Neos Therapeutics, LP | $46.47 | 2019-2020 | |
| Tris Pharma INC | $22.67 | 2023 | Dyanavel Xr |
| Seqirus USA INC | $18.78 | 2025 | Flucelvax |
| Astrazeneca Pharmaceuticals LP | $18.22 | 2024 | Flumist Quadrivalent |
| Collegium Pharmaceutical, INC. | $14.67 | 2025 | Jornay Pm |
| Sobi, INC | $14.63 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $13.23 | 2021 | |
| Shire North American Group INC | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Artigues listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.